Annual Current Ratio
4.08
+2.54+164.94%
December 31, 2023
Summary
- As of February 7, 2025, TSHA annual current ratio is 4.08, with the most recent change of +2.54 (+164.94%) on December 31, 2023.
- During the last 3 years, TSHA annual current ratio has fallen by -32.09 (-88.72%).
- TSHA annual current ratio is now -88.72% below its all-time high of 36.17, reached on December 31, 2020.
Performance
TSHA Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Ratio
5.51
+0.29+5.56%
September 30, 2024
Summary
- As of February 7, 2025, TSHA quarterly current ratio is 5.51, with the most recent change of +0.29 (+5.56%) on September 30, 2024.
- Over the past year, TSHA quarterly current ratio has increased by +4.56 (+480.00%).
- TSHA quarterly current ratio is now -84.77% below its all-time high of 36.17, reached on December 1, 2020.
Performance
TSHA Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Ratio Formula
Current Ratio = Current Assets
Current Liabilities
Current Assets
Current Liabilities
Current Liabilities
TSHA Current Ratio Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +164.9% | +480.0% |
| 3 y3 years | -88.7% | +20.8% |
| 5 y5 years | +3980.0% | - |
TSHA Current Ratio Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +164.9% | at high | +480.0% |
| 5 y | 5-year | -88.7% | +3980.0% | -84.8% | +883.9% |
| alltime | all time | -88.7% | +3980.0% | -84.8% | +883.9% |
Taysha Gene Therapies Current Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 5.51(+5.6%) |
| Jun 2024 | - | 5.22(+54.4%) |
| Mar 2024 | - | 3.38(-17.2%) |
| Dec 2023 | 4.08(+164.9%) | 4.08(+329.5%) |
| Sep 2023 | - | 0.95(-11.2%) |
| Jun 2023 | - | 1.07(-19.5%) |
| Mar 2023 | - | 1.33(-13.6%) |
| Dec 2022 | 1.54 | 1.54(+18.5%) |
| Sep 2022 | - | 1.30(-27.4%) |
| Jun 2022 | - | 1.79(-18.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | 2.20(-28.6%) |
| Dec 2021 | 3.08(-91.5%) | 3.08(-32.5%) |
| Sep 2021 | - | 4.56(-37.5%) |
| Jun 2021 | - | 7.30(-42.2%) |
| Mar 2021 | - | 12.64(-65.1%) |
| Dec 2020 | 36.17(>+9900.0%) | - |
| Dec 2020 | - | 36.17(+50.6%) |
| Sep 2020 | - | 24.02(+4189.3%) |
| Jun 2020 | - | 0.56 |
| Dec 2019 | 0.10 | - |
FAQ
- What is Taysha Gene Therapies annual current ratio?
- What is the all time high annual current ratio for Taysha Gene Therapies?
- What is Taysha Gene Therapies annual current ratio year-on-year change?
- What is Taysha Gene Therapies quarterly current ratio?
- What is the all time high quarterly current ratio for Taysha Gene Therapies?
- What is Taysha Gene Therapies quarterly current ratio year-on-year change?
What is Taysha Gene Therapies annual current ratio?
The current annual current ratio of TSHA is 4.08
What is the all time high annual current ratio for Taysha Gene Therapies?
Taysha Gene Therapies all-time high annual current ratio is 36.17
What is Taysha Gene Therapies annual current ratio year-on-year change?
Over the past year, TSHA annual current ratio has changed by +2.54 (+164.94%)
What is Taysha Gene Therapies quarterly current ratio?
The current quarterly current ratio of TSHA is 5.51
What is the all time high quarterly current ratio for Taysha Gene Therapies?
Taysha Gene Therapies all-time high quarterly current ratio is 36.17
What is Taysha Gene Therapies quarterly current ratio year-on-year change?
Over the past year, TSHA quarterly current ratio has changed by +4.56 (+480.00%)